"Platelet Function Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Laboratory examination used to monitor and evaluate platelet function in a patient's blood.
| Descriptor ID |
D010979
|
| MeSH Number(s) |
E01.370.225.625.625 E05.200.625.625
|
| Concept/Terms |
Platelet Function Tests- Platelet Function Tests
- Function Test, Platelet
- Function Tests, Platelet
- Platelet Function Test
- Test, Platelet Function
- Tests, Platelet Function
|
Below are MeSH descriptors whose meaning is more general than "Platelet Function Tests".
Below are MeSH descriptors whose meaning is more specific than "Platelet Function Tests".
This graph shows the total number of publications written about "Platelet Function Tests" by people in this website by year, and whether "Platelet Function Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platelet Function Tests" by people in Profiles.
-
Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for Complex Cerebral Aneurysms. World Neurosurg. 2020 06; 138:e674-e682.
-
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial. Circ Cardiovasc Interv. 2016 06; 9(6).
-
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv. 2012 Jun; 5(3):347-56.
-
Is platelet function as measured by Thrombelastograph monitoring in whole blood affected by platelet inhibitors? J Extra Corpor Technol. 2005 Mar; 37(1):43-7.
-
Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center. Thromb Haemost. 2000 Jul; 84(1):93-7.
-
Clinical trials of antiplatelet agents in diabetes mellitus: rationale and results. Semin Thromb Hemost. 1991 Oct; 17(4):439-44.
-
The laboratory diagnosis of lupus anticoagulants. Arch Pathol Lab Med. 1989 Feb; 113(2):177-80.
-
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. J Lab Clin Med. 1983 Nov; 102(5):795-804.